The rapid ascent of Chinese-backed micro-dramas into the global entertainment landscape, particularly the lucrative U.S. market, signals a significant shift in content consumption. These bite-sized, vertically-shot narratives, often likened to soap operas on steroids, are capturing audiences with their relentless pacing and instant gratification. Anne Chan, Co-Founder of AR Asia Production, aptly describes them as "Born and the Beautiful on steroids, basically," emphasizing their heightened dramatic flair.
CNBC recently delved into this burgeoning industry, featuring insights from Anne Chan, Co-Founder of AR Asia Production, Seema Shah, Vice President of Research and Insights at Sensor Tower, and Ashley Dudarenok, Founder of ChoZan. Their discussion illuminated the unique characteristics and strategic advantages propelling micro-dramas to a projected $6.9 billion market size in 2024, surpassing China's domestic box office.
